Identification of molecular targets for selective elimination of TRAIL-resistant leukemia cells. From spots to in vitro assays using TOP15 charts

Proteomics

Volumn 9, Issue 22, 2009, Pages 5006-5015

  Petrak, Jiri ^a,b   Toman, Ondrej ^b   Simonova, Tereza ^a   Halada, Petr ^c   Cmejla, Radek ^b   Klener, Pavel ^a   Zivny, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Biomedicine; Drug resistance; HL 60; Leukemia; TOP15; TRAIL

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE PHOSPHATE; CISPLATIN; ETOPOSIDE; MINICHROMOSOME MAINTENANCE PROTEIN 7; REPLICATION FACTOR A; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIDARABINE;

ARTICLE; CANCER RESISTANCE; CELL ASSAY; CELL CLONE; CELL STRAIN HL 60; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA; NUCLEAR PROTEINS; REPLICATION PROTEIN A; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 70949098555     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900335     Document Type: Article

References (20)

1. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S. et al., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3, 673-682. (Pubitemid 26091143)
2. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J. et al., Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996, 271, 12687-12690. (Pubitemid 26175834)
3. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A. et al., Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277, 818-821. (Pubitemid 27366733)
4. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S. et al., Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 1999, 104, 155-162.
5. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B. et al., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 1999, 5,157-163. (Pubitemid 29068521)
6. Plasilova, M., Zivny, J., Jelinek, J., Neuwirtova, R. et al., TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia 2002, 16, 67-73. (Pubitemid 34105601)
7. Zhang, X. D., Nguyen, T., Thomas, W. D., Sanders, J. E., Hersey, P., Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett. 2000, 482, 193-199. (Pubitemid 30750537)
8. Zhang, L., Fang, B., Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 2005, 12, 228-237. (Pubitemid 40315182)
9. Klener, P., Jr., Leahomschi, S., Molinsky, J., Simonova, T. et al., TRAIL-induced apoptosis of HL-60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine. Blood Cells Mol. Dis. 2009, 42, 77-84.
10. Cheng, J. R., Hylander, B. L., Baer, M. R., Chen, X., Repasky, E. A., Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol. Cancer Ther. 2006, 5, 1844-1853. (Pubitemid 44323253)
11. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., CD. Déjá vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749. (Pubitemid 351678270)
12. Wang, P., Bowmann, F. G., Mariman, E. C., Generally detected proteins in comparative proteomics - a matter of cellular stress response? Proteomics 2009, 9, 2955-2966.
13. Ponomarenko, E. A., Lisitsa, A. V., Petrak, J., Moshkovskii, S. A., Archakov, A. I., Identification of differentially expressed proteins using automatic meta-analysis of proteomics-related articles. Biomed. Khim. 2009, 55, 5-14.
14. Labib, K., Tercero, J., Diffley, J., Uninterrupted MCM2-7 function required for DNA replication fork progression, Science 2000, 288, 1643-1647. (Pubitemid 30387430)
15. Forsburg, S. L., Eukaryotic MCM proteins: beyond replication initiation, Microbiol. Mol. Biol. Rev. 2004, 68, 109-131.
16. Zou, Y., Liu, Y., Wu, X., Shell, S. M., Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J. Cell Physiol. 2006, 208, 267-273. (Pubitemid 43993416)
17. Giblett, E. R., Anderson, J. E., Cohen, F., Pollara, B., Meuwissen, H. J., Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972, 2, 1067-1069.
18. Kellems, R. E., Yeung, C. Y., Ingolia, D. E., Adenosine deaminase deficiency and severe combined immunodeficiencies. Trends Genet. 1985, 1, 278.
19. Doherty, P., Pan, S., Milloy, J., Thompson, E. et al., Adenosine deaminase and thymocyte maturation. Scand. J. Immunol. 1991, 33, 405-441.
20. Plunkett, W., Alexander, L., Chubb, S., Loo, T. L., Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase. Cancer Res. 1979, 39, 3655-3660. (Pubitemid 10220174)